dihexa retracted paper controversy Journal pulls by economist who failed to disclose data tinkering – Retraction Watch Retraction | The Transmitter: Neuroscience

Name: dihexa retracted paper controversy Journal pulls by economist who failed to disclose data tinkering – Retraction Watch Retraction | The Transmitter: Neuroscience
Brand: businesscommunicationnetwork.com
SKU: 57920757051
Price: 24.75 USD
Availability: InStock
Rating: 4.8199000000000005 (13 reviews)

SKU: 57920757051

4.8

SEK24.75 SEK59.75

Pay in 4 interest-free payments of $6.19 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Retraction The Transmitter: Neuroscience News and Perspectives dihexa retracted paper controversy Retractions: the good, the bad, and the ugly. What researchers stand to gain from taking more care to understand errors in the scientific record Retractions: Righting the wrongs of science Parkinson's Researcher Notches 17 Retracted Papers The Scientist Why is it so damn hard to get a paper retracted? Researchers plan to retract landmark Alzheimer's paper containing doctored images Science AAAS

Store: businesscommunicationnetwork.com · Domain: businesscommunicationnetwork.com

Description

The BPC-157 oral doses used in preclinical studies is similar to those given in studies with injections at 10mcg/kg [21]

This represents the lower end of effective dosing for most applications

Lyophilized BPC-157 should be stored cold, dry, sealed, and protected from light

This structural mismatch between BPC-157s biology and standard drug development pathways has contributed to the slow pace of clinical trial development, though it has not diminished scientific interest in the compound

of this proposed rule) would complement the proposed growth adjustment

While both peptides have potential applications in muscle, tendon, and ligament repair, their complementary mechanisms suggest some protocols combine them for enhanced recovery outcomes